• For Supporters

Sustainability a major focus of our 17th year partnering with TK Maxx

11 October 2021

• For Researchers
• Science & Technology

Delivering the future of paediatric brain tumour therapy

Dr Lisa Ruff tells us why drug delivery is so important for the treatment of paediatric brain tumours – and why hydrogels could be key to a breakthrough… Dr Lisa Ruff tells us why drug delivery is so important for the treatment of paediatric brain tumours – and why hydrogels could be key to a breakthrough…

7 October 2021

• Health & Medicine

Investigating suspected prostate cancer: Improving GP-patient communication

A study published earlier this year uncovered some important differences in people's experience of visiting the GP. A study published earlier this year uncovered some important differences in people's experience of visiting the GP.

6 October 2021

• Health & Medicine

New drug available for rare thyroid cancer on NHS in England

The National Institute for Health and Care Excellence (NICE) has recommended the use of the drug selpercatinib (Retevmo) for some people in England with a type of advanced thyroid cancer. The National Institute for Health and Care Excellence (NICE) has recommended the use of the drug selpercatinib (Retevmo) for some people in England with a type of advanced thyroid cancer.

1 October 2021

• Health & Medicine

Cancer in children and young people: how far we’ve come

Since the 1970s, 30,000 deaths have been avoided thanks in part to the progress we’ve made in diagnosing and treating children's and young people's cancers. Since the 1970s, 30,000 deaths have been avoided thanks in part to the progress we’ve made in diagnosing and treating children's and young people's cancers.

29 September 2021

• Science & Technology

A winding journey into the world of children’s and young people’s cancer research

We hear from two Cancer Research UK scientists, Ashley Nicholls and Jessica Taylor, about their interesting career changes. We hear from two Cancer Research UK scientists, Ashley Nicholls and Jessica Taylor, about their interesting career changes.

24 September 2021

• Science & Technology
• Health & Medicine

Precision drug slows progression of advanced breast cancer

Patients taking the drug trastuzumab deruxecan were 72% less likely to see their cancer grow significantly or to die than those on an existing breast cancer treatment. Patients taking the drug trastuzumab deruxecan were 72% less likely to see their cancer grow significantly or to die than those on an existing breast cancer treatment.

21 September 2021

• Science & Technology
• Health & Medicine

Combining existing drugs improves prostate cancer survival

Adding abiraterone to standard hormone therapy improves survival for men with high-risk prostate cancer, according to findings presented at the ESMO conference. Adding abiraterone to standard hormone therapy improves survival for men with high-risk prostate cancer, according to findings presented at the ESMO conference.

19 September 2021

• Personal Stories

Coronavirus reports – Part 10: “I didn’t see my mum before I went into surgery”

This Childhood Cancer Awareness Month, we caught up with families who have been affected by children’s and young people’s cancers to find out how COVID-19 has impacted them and their loved ones. This Childhood Cancer Awareness Month, we caught up with families who have been affected by children’s and young people’s cancers to find out how COVID-19 has impacted them and their loved ones.

15 September 2021

• Health & Medicine

New chemotherapy-free treatment for bowel cancer made available in Scotland

Pembrolizumab will be made available for some adults in Scotland with bowel cancer that’s spread to other parts of the body.   Pembrolizumab will be made available for some adults in Scotland with bowel cancer that’s spread to other parts of the body.  

14 September 2021

• Health & Medicine

Hormone therapy gets green light for advanced prostate cancer

Adults in England with advanced hormone-sensitive prostate cancer that’s spread to other parts of the body will now have a new treatment option. Adults in England with advanced hormone-sensitive prostate cancer that’s spread to other parts of the body will now have a new treatment option.

14 September 2021